148 related articles for article (PubMed ID: 37524216)
1. Association of protective behaviors with SARS-CoV-2 infection: results from a longitudinal cohort study of adults in the San Francisco Bay Area.
Judson TJ; Zhang S; Lindan CP; Boothroyd D; Grumbach K; Bollyky JB; Sample HA; Huang B; Desai M; Gonzales R; Maldonado Y; Rutherford G;
Ann Epidemiol; 2023 Oct; 86():1-7. PubMed ID: 37524216
[TBL] [Abstract][Full Text] [Related]
2. Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area.
Lindan CP; Desai M; Boothroyd D; Judson T; Bollyky J; Sample H; Weng Y; Cheng Y; Dahlen A; Hedlin H; Grumbach K; Henne J; Garcia S; Gonzales R; Craik CS; Rutherford G; Maldonado Y
Ann Epidemiol; 2022 Mar; 67():81-100. PubMed ID: 34800659
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; von Buchwald C; Todsen T; Norsk JB; Pries-Heje MM; Vissing CR; Nielsen PB; Winsløw UC; Fogh K; Hasselbalch R; Kristensen JH; Ringgaard A; Porsborg Andersen M; Goecke NB; Trebbien R; Skovgaard K; Benfield T; Ullum H; Torp-Pedersen C; Iversen K
Ann Intern Med; 2021 Mar; 174(3):335-343. PubMed ID: 33205991
[TBL] [Abstract][Full Text] [Related]
4. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
5. Disparities and Temporal Trends in COVID-19 Exposures and Mitigating Behaviors Among Black and Hispanic Adults in an Urban Setting.
Badri S; Sardá V; Moncada JS; Merçon M; Rezai K; Weinstein RA; Trick WE
JAMA Netw Open; 2021 Sep; 4(9):e2125187. PubMed ID: 34581798
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal social contacts among school-aged children during the COVID-19 pandemic: the Bay Area Contacts among Kids (BACK) study.
Andrejko KL; Head JR; Lewnard JA; Remais JV
BMC Infect Dis; 2022 Mar; 22(1):242. PubMed ID: 35272626
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
8. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
[TBL] [Abstract][Full Text] [Related]
9. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco.
Chamie G; Marquez C; Crawford E; Peng J; Petersen M; Schwab D; Schwab J; Martinez J; Jones D; Black D; Gandhi M; Kerkhoff AD; Jain V; Sergi F; Jacobo J; Rojas S; Tulier-Laiwa V; Gallardo-Brown T; Appa A; Chiu C; Rodgers M; Hackett J; ; Kistler A; Hao S; Kamm J; Dynerman D; Batson J; Greenhouse B; DeRisi J; Havlir DV
Clin Infect Dis; 2021 Jul; 73(Suppl 2):S127-S135. PubMed ID: 32821935
[TBL] [Abstract][Full Text] [Related]
10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
11. Protective behavior and SARS-CoV-2 infection risk in the population - Results from the Gutenberg COVID-19 study.
Baumkötter R; Yilmaz S; Zahn D; Fenzl K; Prochaska JH; Rossmann H; Schmidtmann I; Schuster AK; Beutel ME; Lackner KJ; Münzel T; Wild PS
BMC Public Health; 2022 Oct; 22(1):1993. PubMed ID: 36316662
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
Doernberg SB; Holubar M; Jain V; Weng Y; Lu D; Bollyky JB; Sample H; Huang B; Craik CS; Desai M; Rutherford GW; Maldonado Y;
Clin Infect Dis; 2022 Oct; 75(9):1573-1584. PubMed ID: 35279023
[TBL] [Abstract][Full Text] [Related]
13. The Impact of the first COVID-19 shelter-in-place announcement on social distancing, difficulty in daily activities, and levels of concern in the San Francisco Bay Area: A cross-sectional social media survey.
Elser H; Kiang MV; John EM; Simard JF; Bondy M; Nelson LM; Chen WT; Linos E
PLoS One; 2021; 16(1):e0244819. PubMed ID: 33444363
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
16. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
[TBL] [Abstract][Full Text] [Related]
17. Wildfire and COVID-19 pandemic: effect of environmental pollution PM-2.5 and carbon monoxide on the dynamics of daily cases and deaths due to SARS-COV-2 infection in San-Francisco USA.
Meo SA; Abukhalaf AA; Alomar AA; Alessa OM
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10286-10292. PubMed ID: 33090440
[TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
19. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
[TBL] [Abstract][Full Text] [Related]
20. Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis.
Landi D; Ponzano M; Nicoletti CG; Cecchi G; Cola G; Mataluni G; Mercuri NB; Sormani MP; Marfia GA
Mult Scler Relat Disord; 2020 Oct; 45():102359. PubMed ID: 32663793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
